SEIA
CRL icon

Signature Estate & Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Signature Estate & Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,061
Closed -$2.36M – 186
2023
Q3 		$2.36M Buy
12,061
+465
+4% +$95.5K 0.08% 74
2023
Q2 		$2.44M Buy
11,596
+819
+8% +$163K 0.08% 70
2023
Q1 		$2.17M Buy
10,777
+902
+9% +$204K 0.08% 76
2022
Q4 		$2.15M Buy
9,875
+379
+4% +$82.8K 0.08% 79
2022
Q3 		$1.87M Buy
9,496
+964
+11% +$208K 0.09% 71
2022
Q2 		$1.82M Buy
8,532
+1,853
+28% +$453K 0.09% 70
2022
Q1 		$1.9M Buy
6,679
+814
+14% +$251K 0.09% 69
2021
Q4 		$2.21M Buy
5,865
+548
+10% +$213K 0.1% 69
2021
Q3 		$2.19M Sell
5,317
-570
-10% -$237K 0.11% 62
2021
Q2 		$2.18M Sell
5,887
-933
-14% -$312K 0.1% 60
2021
Q1 		$1.98M Buy
6,820
+255
+4% +$70.9K 0.1% 67
2020
Q4 		$1.64M Sell
6,565
-93
-1% -$22.1K 0.09% 73
2020
Q3 		$1.51M Sell
6,658
-643
-9% -$133K 0.09% 66
2020
Q2 		$1.27M Sell
7,301
-810
-10% -$129K 0.09% 74
2020
Q1 		$1.02M Buy
+8,111
New +$1.22M 0.08% 85

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Signature Estate & Investment Advisors's CRL Position: Q4 2023 in Review

Signature Estate & Investment Advisors sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 12,061 shares — an estimated $2.36M sold.

Signature Estate & Investment Advisors first reported a position in CRL in Q1 2020 and held it in 15 quarters. The position peaked at $2.44M in Q2 2023. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Signature Estate & Investment Advisors reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 12,061 Charles River Laboratories shares in Q4 2023, an estimated $2.36M.
  • Signature Estate & Investment Advisors first reported a position in Charles River Laboratories in Q1 2020 and held it in 15 quarters.
  • Signature Estate & Investment Advisors's Charles River Laboratories position peaked at $2.44M in Q2 2023.
  • 634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Signature Estate & Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.